Equity Profile
Post-Earnings Recap
Halozyme Therapeutics, Inc.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.86 | $-0.89 | +19.63% |
| Revenue | $0M | $0M | N/A |
management commentary, guidance changes, and full analysis available with Pro.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Celcuity Inc. is a biotechnology company focused on developing innovative treatments for cancer....
EPS
Earnings per share (EPS) is a key indicator of profitability, and investors will be looking to see if the company can narrow its losses.
Revenue
While no revenue is expected this quarter, any updates on future revenue potential could impact investor sentiment.
Wall Street expectations, options signals, track record, and call prep available with Pro.